CytomX Therapeutics CTMX Q1 2025 earnings
Reported May 12, 2025 · Before market open
Revenue$50.9MBeat by $15.5M
EPS$0.27Beat by $0.15
Revenue estimate$35.4M
EPS estimate$0.12
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$12.4M
EPS estimate-$0.11
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment CytomX Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did CytomX Therapeutics report Q1 2025 earnings?
- CytomX Therapeutics (CTMX) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were CytomX Therapeutics's Q1 2025 revenue and EPS?
- CytomX Therapeutics reported revenue of $50.9M and eps of $0.27 for Q1 2025.
- Did CytomX Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $35.4M by $15.5M. EPS beat the consensus estimate of $0.12 by $0.15.
- How did CytomX Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 22.8% from $41.5M a year earlier and eps grew 58.8% from $0.17.
- Where can I find CytomX Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-068511) directly on SEC EDGAR. The filing index links above go to sec.gov.